Skip to content

Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy

Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03575286
Enrollment
123
Registered
2018-07-02
Start date
2018-06-28
Completion date
2019-03-31
Last updated
2018-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Keywords

Pregnancy, Urine Testing, Medical Diagnostics

Brief summary

The primary purpose of this observational study is to demonstrate the feasibility of an automated point-of-care urine diagnostic device in determining the pregnancy status of patients through urine samples collected from patients at Northwestern University. Our hypothesis is that this automated point-of-care urine diagnostic device will be able to accurately determine a patient's pregnancy status at least 95% of the time.

Interventions

DIAGNOSTIC_TESTPregnancy test

Detects hormone (hCG, Human Chorionic Gonadotropin) produced by the body during pregnancy

Sponsors

Northwestern University
CollaboratorOTHER
Voyant Diagnostics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient age 18 years and older, upper age limit of 45 years * Female patient * Patients undergoing any procedures for pregnancy diagnosis and confirmation * English speaking The following special population will be included: * Pregnant women

Exclusion criteria

* Adults unable to consent * Individuals who are not yet adults (infants, children, and teenagers) * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Accuracy in determining pregnancy statusTime of collection - 1 month post collectionCompare qualitative pregnancy test results generated by Voyant's device with urine pregnancy test result(s) and, if applicable, serum pregnancy test results performed at Northwestern University. From this comparison, we will determine the accuracy of Voyant's device. We will be using the same urine sample used at Northwestern.

Countries

United States

Contacts

Primary ContactMichael Tu, MS, BS
michael.tu@voyant.health214-415-4288
Backup ContactClaire Y Zhou, BA
claire.zhou@voyant.health949-355-3695

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026